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Abstract
Ras homologue enriched in striatum (Rhes) is a small
monomeric G protein which functions in a variety of
cellular processes, including attenuation of G protein-
coupled receptor (GPCR) signalling. There have been
many studies into the effects of Rhes, but there is no
molecular information about how Rhes might bring
about these effects. Rhes shares striking sequence
homology to AGS1 (activator of G protein signalling
1) and we considered whether the two proteins
function in similar ways. AGS1 binds to the Gβ1 subunit
of heterotrimeric G proteins and we have used yeast
two-hybrid studies to show that Rhes binds selectively
to Gβ1, Gβ2 and Gβ3 subunits. Binding to the Gβ
subunits involves the cationic regions of AGS1 and
Rhes, and we used Rhes-AGS1 chimeras to show
that their different cationic regions determine the Gβ-
specificity of the interactions. Possible implications
of this interaction for the activity of Rhes are
discussed.
Introduction
The Ras superfamily of small GTPases comprises
several protein subfamilies (Figure 1, [1]). Sequence
analysis identifies two family members, Rhes and AGS1,
as a distinct subclass with an additional domain in the
carboxyl terminal region of the protein. This domain has
been termed the “cationic region” as it is enriched in
positively charged residues. As well as their sequence
similarity, both proteins are expressed in response to
hormones; Rhes expression is regulated by thyroid
hormone during the postnatal period [2], whereas AGS1
is induced by dexamethasone (as indicated by its original
name Dexras1) [3]. Both proteins have also been
implicated in signalling pathways downstream of G protein-
coupled receptors (GPCRs).
GPCRs represent the largest family of cell surface
receptors and are characterised by seven transmembrane
helices. In the unstimulated state, the receptor is associated
with a heterotrimeric complex of Gα, Gβ and Gγ subunits
in which the Gα subunit is bound to GDP. Activation of
the receptor stimulates the exchange of GDP for GTP,
releasing the Gα-GTP and Gβγ subunits to activate a
variety of downstream effectors that are responsible for
2bringing about the changes in cell behaviour. Gα proteins
possess an intrinsic GTPase activity and GTP hydrolysis
returns the heterotrimer to its inactive state. The
specificity, magnitude and duration of GPCR signalling is
further regulated by accessory proteins that interact with
the receptors, the G proteins or the effectors. These
include receptor kinases (reviewed by [4]), regulator of
G protein signalling (RGS) proteins (reviewed by [5, 6]),
and activator of G protein signalling (AGS) proteins
(reviewed by [7, 8]). The realisation that heterotrimeric
G proteins can function in cellular processes independently
of the receptors [9] illustrates how significant the
regulation by these accessory proteins can be in some
circumstances.
AGS1/DexRas1 was first identified in mice [3] and
its human homologue was isolated in a yeast screen for
receptor-independent activators of heterotrimeric G
proteins [10, 11]. In vitro analyses suggested that AGS1
mimics activated receptors by binding to Gα subunits and
promoting nucleotide exchange [10, 11], and is consistent
with in vivo evidence that AGS1 activates both Gα- [12,
13] and Gβγ-mediated signalling pathways [11, 14] in the
absence of ligand. However, the ability of AGS1 to inhibit
receptor-activated Gβγ-mediated signalling [11, 14-16]
suggested additional activities and we previously used
yeast two-hybrid analysis to reveal a novel interaction
between AGS1 and Gβ1 [17]. The interaction between
the C-terminal cationic region of AGS1 and blades 3-to-
7 of the Gβ1 propeller structure might explain how AGS1
promotes Gαβγ dissociation in the absence of receptor
stimulation but selectively inhibits Gβγ-mediated signalling
in receptor-stimulated pathways [8].
There is increasing evidence that Rhes regulates
signalling pathways involving GPCRs and heterotrimeric
G proteins; it attenuates signalling via the cAMP/PKA
pathway mediated by both wild-type thyroid stimulating
hormone (TSH) receptors and constitutively active β2-
adrenergic receptors [18], inhibits signalling from a variety
of other receptors [19], and modulates dopamine signalling
[20]. How Rhes achieves this is unclear, although its lack
of effect on either a constitutively active Gα subunit or a
directly activated effector protein (protein kinase A
activated by forskolin) [18] suggests that Rhes might be
acting on the heterotrimeric Gαβγ complex. Given the
functional similarity between Rhes and AGS1, and the
striking sequence homology between the two proteins
(particularly with regards to their novel cationic regions),
we investigated whether Rhes, like AGS1, interacts with
Gβ subunits. Using the yeast two-hybrid system, we
demonstrate that Rhes interacts selectively with Gβ1, Gβ2
and Gβ3 and that the interaction, like that between AGS1
and Gβ1 [17], involves the cationic region of Rhes and
blades 3-to-7 of the Gβ propellers. Analysis of AGS1-
Rhes chimeras suggests that the different cationic regions
specify their interactions with the Gβ subunits. The
interaction between Rhes and Gβ subunits revealed in
this study could explain how Rhes can influence signalling
through heterotrimeric G proteins.
Materials and Methods
Yeast two-hybrid assays
The AH109 Saccharomyces cerevisiae strain, pGADT7-
SV40, pGBKT7-p53, and pGBKT7-lamin-C constructs used in
this study were supplied with the Matchmaker yeast two-hybrid
kit and all yeast-based methods were carried out as detailed by
the manufacturer (BD Biosciences Clontech, Oxford, UK; kit
version PT13529-1). Two-hybrid assays were carried out
following sequential transformations of AH109 with pGBKT7-
based plasmids and then pGADT7-based plasmids. Co-
Fig 1. Sequence comparison of Rhes, AGS1 and mammalian
H-Ras. Sequences were aligned using MultAlin version 5.4.1.
[36] using symbol comparisontable blosum62, gap weight 12
and gap length weight 2. Gaps introducedto maximise the
alignment are indicated by '-'. Residues shaded in black are
conserved in all three proteins, those in grey are in two of the
proteins. Boxed regions correspond to interactions for the
phosphate moieties of GTP/GDP (G1, G3), the GAP effector
(G2), and the guanine nucleotide moiety (G4, G5). The cationic
region (residues Met189-Ala235 of Rhes) is indicated by *.
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3transformants were maintained on MM (a defined minimal
medium lacking leucine and tryptophan) prior to screening for
interactions. Cell concentrations were determined using a
Coulter Channelyser (Beckman-Coulter, Luton, UK). All
experiments to investigate interactions and protein expression
were repeated at least three times with different isolates.
DNA constructs
DNA manipulations were performed by standard methods.
Amplification by the polymerase chain reaction (PCR) was
performed in 70 µl reactions using Pwo DNA polymerase from
Pyrococcus woesei according to the supplier’s instructions
(Roche Molecular Biochemicals, Lewes, UK). Oligonucleotides
were synthesised by TAGN Newcastle (Gateshead,
Northumbria, UK). All DNA constructs were sequenced to
confirm that no errors had been introduced during amplification.
The full-length Gβ subunits (Gβ1, Gβ2, Gβ3, Gβ4 and Gβ5)
and the deleted Gβ1 constructs (Gβ1WD1-7, Gβ1WD3-7, Gβ1WD5-7)
were expressed as fusions with the GAL4 Activation Domain
from the pGADT7 vector as described previously [17].
The Rhes open reading frame (ORF) was amplified by
PCR from placental cDNA using JO1939 (5’ ggg catATG ATG
AAG ACT TTG TCC AGC, sense primer containing an NdeI
site and initiator codon in bold, lowercase letters indicate
sequence not found within the gene being amplified) and
JO1940 (5’ ggg gat ccTCA CTG GAT GGT GCA CTT GTC CCT
CT; antisense primer containing a BamHI site and TCA stop
anticodon) and cloned into the NdeI-BamHI sites of the yeast
two-hybrid bait vector pGBKT7 to generate pGBKT7-Rhes.
RhesΔCR (Rhes construct lacking the region Met189-Ala235)
was generated by inverse PCR on pGBKT7-Rhes using JO2179
(5’ CGC CGC CCC AGC GTC AAC AGT GAC CTC AAG; sense
primer containing the CGC codon corresponding to Arg236 of
Rhes) and JO2178 (5’ GCT GAA GAG CAC GTA GAA CAT
CTC G; antisense primer containing the GCT anticodon
corresponding to Ser188 of Rhes) and ligating the product to
itself.
Rhes189-235 (construct corresponding to the region Met189-
Ala235 of Rhes) was amplified using JO2184 (5’ ggg
catATGGCCAAGCTGCCCCACGAGAT; sense primer
containing an NdeI site and the ATG codon corresponding to
Met189 of Rhes) and JO2185 (5’ ggg gat cct caGGC GAA GGG
CGA GAC CAT GCC AT; antisense primer containing a BamHI
site and a stop anticodon immediately downstream of the GGC
anticodon corresponding to Ala235 of Rhes) with pGBKT7-Rhes
as template.) and cloned into the NdeI-BamHI sites of the yeast
two-hybrid bait vector pGBKT7 to generate pGBKT7-
Rhes189-235.
RhesCR-AGS1 (construct in which the cationic region of Rhes
[Met189-Ala235] was replaced by the equivalent region of AGS1
[Met194-Ala250]) was created by ligating the inverse PCR product
generated for the construction of RhesΔCR (see above) to the
PCR product obtained on pGBKT7-AGS1 [17] using JO2175
(5’ ATG GCC AAG CTG CCC AGC GAG; sense primer
containing the ATG codon corresponding to Met194 of AGS1)
and JO2174 (5’ CGC GAA GGG TGC CAC GAT GCC AAA GGC;
antisense primer containing the CGC anticodon corresponding
to Ala250 of AGS1).
AGS1CR-Rhes (construct in which the cationic region of AGS1
[Met194-Ala250] was replaced by the equivalent region of Rhes
[Met189-Ala235]) was created by ligating the product generated
by PCR on pGBKT7-Rhes with JO2181 (5’ ATG GCC AAG CTG
CCA CAC GAG; sense primer containing the ATG codon
corresponding to Met189 in Rhes) and JO2180 (5’ GGC GAA
GGG CGA GAC CAT GCC; antisense primer containing the
GGC anticodon corresponding to Ala235 of Rhes) to the product
obtained by inverse PCR on pGBKT7-AGS1 using JO2173 (5’
CGC CGG CCC AGC GTA CAC AGC; sense primer containing
the CGC codon corresponding to Arg251 in AGS1) and JO2172
(5’ GGC GAA GAG CGC GCG GAA CAT CTG; antisense primer
containing the GGC anticodon corresponding to Ala193 of
AGS1).
Western blotting
Western blotting was performed as described previously
[17]. Mouse monoclonal anti-GAL4 binding domain (BD) and
mouse monoclonal anti-GAL4 activation domain (AD) were
used according to manufacturers’ instructions (BD Biosciences,
Oxford, UK). HRP-conjugated secondary antibodies were from
either Amersham plc (Little Chalfont, UK) or Roche Diagnostics
(Lewes, UK) and used according to the manufacturer’s
instructions.
Results
Rhes binds selectively to human Gβ subunits
Yeast two-hybrid analysis was used to investigate
interactions between Rhes and each of the five human
Gβ subunits (Figure 2). The yeast screening strain AH109
was transformed first with pGBKT7-Rhes and then with
the various pGADT7-Gβ constructs and co-transformants
isolated on selective medium. Growth on MM (a defined
minimal medium lacking leucine and tryptophan)
confirmed the presence of the complementing plasmids
in each isolate. The formation of blue colonies on MM-
His-Ade+Xαgal (MM lacking histidine and adenine but
incorporating 5-bromo-4-chloro-3-indolyl-α-D-galactoside
[Xαgal]) indicated that interaction between Rhes and the
Gβ1, Gβ2 and Gβ3 subunits (but not Gβ4 nor Gβ5) had
resulted in expression of the HIS3, ADE2 and MEL1
reporter genes. A positive control for interacting proteins
was provided by transformants expressing SV40-T
antigen and p53, proteins that interact strongly [21]. In
contrast, SV40-T antigen does not interact with lamin-C
and co-transformants were unable to grow on plates
lacking histidine and adenine. Immunoblotting confirmed
expression of Rhes and each of the Gβ subunits in the
various transformants; fusion of Rhes to the GAL4 DNA
binding domain (BD) in pGBKT7 increases its MW from
~30 kDa to ~53 kDa (note that the antibody to GAL4-
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4BD detects a faint product at ~35 kDa in all samples,
including those not expressing the fusion protein), fusion
of the Gβ subunits to the GAL4 activation domain (AD)
in pGADT7 increases their MWs from ~37 kDa to ~55
kDa. The interactions were quantitated using a liquid-
based β-galactosidase assay for expression of the LacZ
reporter gene. Under the conditions used, strongly
interacting proteins (such as SV40-T antigen and p53)
generate ~4.5 Units of β-galactosidase activity, while non-
interacting proteins (such as SV40-T antigen and lamin-
C) generate less than 0.5 Units. Co-transformants
expressing Rhes and Gβ1, Gβ2 or Gβ3 produced ~3 Units
of activity, suggesting a reasonably strong interaction. In
contrast, strains expressing Rhes and either Gβ4 or Gβ5
produced less than 0.5 Units, indicating these proteins do
not interact.
Neither Rhes nor any of the Gβ subunits supported
growth on the MM-His-Ade+Xαgal plates when
expressed on their own (not shown), demonstrating they
have no inherent ability to activate transcription of the
reporter constructs. Furthermore, transferring Rhes and
the Gβ subunits from their original two-hybrid plasmids
to the complementing plasmids to provide the reciprocal
pairing for analysis generated interactions that were
indistinguishable from those in Figure 2, confirming that
induction of reporter activity was due to an interaction
between Rhes and Gβ1, Gβ2 and Gβ3 and not to non-
specific effects arising from expression of these proteins
as fusions with either the GAL4 binding domain or GAL4
activation domains. We have shown previously that each
Gβ subunit was able to interact in the two-hybrid system
with Gγ4 [22], a human Gγ subunit that binds to Gβ
subunits in vivo [23].
Mapping the Rhes interaction site on Gβ1
Gβ subunits contain two structurally distinct domains,
an N-terminal α-helix of ~20 amino acids which forms a
coiled-coil interaction with Gγ subunits, and a seven-bladed
propeller structure formed from the repeating WD repeat
motifs that is believed to interact with binding partners
[17, 24-26]. Each propeller blade consists of a single WD
repeat organised into four twisted β-strands, and variable
regions between each repeat make it straightforward to
generate constructs containing different numbers of
Fig 2. Rhes interacts specifically with Gβ1,
Gβ2 and Gβ3. A) Rhes (expressed from
pGBKT7-Rhes) was co-expressed with each
of the human Gβ subunits (expressed from
pGADT7). All transformants grew on MM
but only those containing Gβ1, Gβ2 or Gβ3
grew on MM-His-Ade+XαGal, suggesting
that only these Gβ subunits interact with
Rhes to induce expression of the reporter
genes. Control strains expressing the
strongly interacting SV40-T antigen and p53
or the non-interacting SV40-T and lamin-C
are included for comparison. A liquid-based
β-galactosidase assay confirms that co-
expression of Rhes and Gβ1, Gβ2 or Gβ3
induces expression of the LacZ reporter. B)
Rhes was expressed separately with various
Gβ1 constructs lacking different parts of the
protein. All transformants grew on MM but
those containing Gβ1WD5–7 were unable grow
on MM-His-Ade+XαGal, suggesting that
this construct was unable to interact with
Rhes. Expression of Rhes in each strain was
confirmed by immunoblotting with an
antibody to the GAL4-BD (Rhes was fused to the GAL4 binding domain; note that the antibody to GAL4-BD detects a faint
product at ~35 kDa in all samples, including those not expressing the Rhes fusion protein), and expression of the various Gβ
constructs were confirmed by immunoblotting with an antibody to the GAL4-AD (the Gβ constructs are fused to the GAL4
activation domain). At least three separate isolates of each strain were subjected to immunoblotting to confirm that the results
shown are representative. The β-galactosidase results are presented as the mean ± SD of three different isolates of the relevant
strain, each with duplicate determinations.
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5Fig 3. Binding of Gβ
subunits to the cationic
region of Rhes. A) Rhes
lacking the cationic
region (expressed from
pGBKT7-RhesΔCR, lacks
residues Met189-to-
Ala235) was co-expressed
with each of the Gβ
subunits (expressed from
pGADT7). All
transformants grew on
MM but none grew on
MM-His-Ade+XαGal,
suggesting that the
cationic region of Rhes
is essential for
interaction with the Gβ
subunits. The liquid-
based β-galactosidase
assay confirms that none
of the combinations
induced expression of
the LacZ reporter. B) The
cationic region of Rhes
(expressed from
p G B K T 7 - R h e s 1 8 9 - 2 3 5,
contains only those residues from Met189-to-Ala235) was co-expressed with human Gβ subunits (expressed from pGADT7). All
transformants grew on MM but only those containing Gβ1, Gβ2 or Gβ3 grew on MM-His-Ade+XαGal, suggesting that the
cationic region of Rhes is sufficient for the interaction with these Gβ subunits. The liquid-based β-galactosidase assay confirms
that co-expression of Rhes189-235 and Gβ1, Gβ2 or Gβ3 induces expression of the LacZ reporter. Expression of the various Rhes
constructs were confirmed by immunoblotting with an antibody to the GAL4-BD (the Rhes constructs were fused to the GAL4
binding domain), and expression of the various Gβ constructs were confirmed by immunoblotting with an antibody to the GAL4-
AD (the Gβ constructs were fused to the GAL4 activation domain). At least three separate isolates of each strain were subjected
to immunoblotting to confirm that the results shown are representative. The β-galactosidase results are presented as the mean ±
SD of three different isolates of the relevant strain, each with duplicate determinations.
blades. As constructs require an odd number of blades to
be stable, and blade 7 provides a ‘velcro snap’ to close
the propeller, only a limited series of Gβ1 constructs were
tested for their ability to interact with Rhes (Figure 2B).
Immunoblotting demonstrated expression of Rhes and
each of the Gβ1 constructs (Gβ1 constructs are expressed
as fusions to the activation domain from pGADT7 and
were detected using an antibody to the activation domain,
and the activation domain adds ~18 kDa to the MW of
the Gβ1 constructs), while control experiments confirmed
that neither Rhes nor the Gβ1 constructs were able to
induce reporter genes when expressed on their own (not
shown). Removal of either the N-terminal α-helix or the
first two propeller blades of Gβ1 did not affect its
interaction with Rhes. However, Gβ1WD5-7 (lacks blades
1-to-4) failed to interact with Rhes, suggesting that this
region is required for the interaction. The same region of
Gβ1 was previously identified as being required for its
interaction with AGS1 [17].
Mapping the Gβ interaction site on Rhes
Rhes is similar to Ras and other small monomeric G
proteins except for a C-terminal cationic region (residues
Met189-Ala235; Figure 1). A similar cationic region in the
highly homologous AGS1 mediates its interaction with
both the neuronal nitric oxide adaptor protein CAPON
[27] and Gβ1 [17], and we used two-hybrid analysis to
investigate the role of this region in the interaction of Rhes
with the Gβ subunits (Figure 3). Immunoblotting confirmed
that all of the constructs were expressed, and none of
the constructs induced expression of the reporter genes
when present on their own (not shown). A Rhes construct
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6lacking the cationic region (RhesΔCR, lacks residues
Met189-Ala235) failed to interact with any of the Gβ
subunits (Figure 3A), whereas a construct containing just
this region of Rhes (fused to the GAL4 binding domain)
interacted with Gβ1, Gβ2 and Gβ3 (Figure 3B). Thus, the
cationic region of Rhes is not only required for its
interactions with Gβ subunits but appears to be sufficient
for these interactions.
The cationic region determines the specificity of
the Gβ interactions
The cationic regions of both AGS1 [17] and Rhes
(Figure 3) are required for their interactions with Gβ
subunits. However, the two regions are very different in
the two proteins (Figure 1) and we wondered whether
these differences were responsible for their different Gβ
specificities; both AGS1 and Rhes bind to Gβ1, but only
Rhes also binds to Gβ2 and Gβ3. We therefore generated
constructs that exchanged the cationic regions between
the two proteins, and used two-hybrid analysis to examine
their ability to interact with the various Gβ subunits (Figure
4). Immunoblotting confirmed that all of the constructs
were expressed, and none of the constructs induced
expression of the reporter genes when present on their
Fig 4. The cationic regions of Rhes and AGS1
determine the specificity of their binding to Gβ
subunits. A) Rhes containing the cationic region
from AGS1 (pGBKT7-RhesCR-AGS1, residues Met189-
to-Ala235 of Rhes replaced by residues Met194-to-
Ala250 of AGS1) was co-expressed with the human
Gβ1, Gβ2 and Gβ3 subunits (expressed from
pGADT7). All transformants grew on MM but only
the transformant containing Gβ1 grew on MM-His-
Ade+XαGal and induced expression of the LacZ
reporter, suggesting that RhesCR-AGS1 interacts with
only Gβ1. B) AGS1 containing the catioinic region
of Rhes (pGBKT7-AGS1CR-Rhes, residues Met194-to-
Ala250 of AGS1 replaced by residues Met189-to-
Ala235 of Rhes) was co-expressed with the human
Gβ1, Gβ2 and Gβ3 subunits (expressed from
pGADT7). All transformants grew on MM and MM-
His-Ade+XαGal, and all induced expression of the
LacZ reporter, suggesting that AGS1CR-Rhes interacts
with all three Gβ subunits. Expression of RhesCR-
AGS1 and AGS1CR-Rhes were confirmed by
immunoblotting with an antibody to the GAL4-BD
(the constructs are fused to the GAL4 binding
domain), and expression of the Gβ constructs were
confirmed by immunoblotting with an antibody to
own (not shown). RhesCR-AGS1, which has residues Met189-
Ala235 of Rhes replaced by residues Met194-Ala250 of
AGS1, interacted with only Gβ1 and, unlike wild type Rhes,
was unable to interact with either Gβ2 or Gβ3 (Figure
4A). In contrast, AGS1CR-Rhes, (Met194-Ala250 of AGS1
replaced by residues Met189-Ala235 of Rhes) interacted
with Gβ1, Gβ2 and Gβ3 (Figure 4B). These results suggest
that the different cationic regions of Rhes and AGS1
interact with different Gβ subunits.
Discussion
Our data suggest that Rhes interacts specifically with
the Gβ1, Gβ2 and Gβ3 subunits of heterotrimeric G
proteins, but not Gβ4 or Gβ5. The interaction involves the
C-terminal cationic region of Rhes and blades 3-to-7 of
the Gβ subunits, and appears similar to the interaction
between the cationic region of AGS1 and blades 3-to-7
of Gβ1 [17]. Indeed, exchanging the cationic regions
between Rhes and AGS1 alters the Gβ-binding
specificities of the chimeras.
The interaction of Rhes with the Gβ subunits requires
its C-terminal cationic region. This region identifies Rhes
the GAL4-AD (the constructs are fused to the GAL4 activation domain). At least three separate isolates of each strain were
subjected to immunoblotting to confirm that the results shown are representative. The β-galactosidase results are presented as
the mean ± SD of three different isolates of the relevant strain, each with duplicate determinations.
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7and AGS1 within the Ras-like family of small G proteins
and was previously shown to mediate the interaction of
AGS1 with Gβ1 [17]. Despite both binding to Gβ1, there
is no obvious sequence homology between the cationic
regions of Rhes and AGS1, and any shared activities are
presumably not dependent upon precise residues. But
there is a level of specificity in the interaction in that the
cationic region of AGS1 interacts with Gβ1 while the
cationic region of Rhes also interacts with Gβ2 and Gβ3.
The cationic region of AGS1 also interacts with the
neuronal nitric oxide adaptor protein CAPON [27]. It is
therefore possible that this domain allows both AGS1 and
Rhes to interact with a wide variety of other molecules.
These may be responsible for the effects of Rhes and
AGS1 that do not appear to be mediated through G
proteins.
The Rhes-Gβ1 interaction requires blades 3-to-7 of
the Gβ β-propeller. Given the conservation of sequence
and structure between Gβ subunits, it seems likely that
the same regions of Gβ2 and Gβ3 are involved in their
interaction with Rhes. Our previous study identified the
same region of Gβ1 to be involved in its interaction with
AGS1 [17]. This region of Gβ1 is not generally thought to
be involved in interactions with its other binding partners.
Gγ subunits, for example, form a coiled-coil interaction
with the N-terminal α-helix of the Gβ subunit [28], while
Gα subunits are believed to interact with blades 1-to-3 of
the β-propeller [28], and target effector proteins primarily
contact the outer segments of blades 1 and 2 [29, 30].
However, overlapping binding sites and more complex
interactions, especially between Gβ subunits and target
effectors, might further complicate the interactions. We
cannot, for example, rule out a requirement for blade 3 in
binding Rhes, or AGS1, as well as its role in binding Gα
subunits. It is also possible that binding of a protein to one
part of the Gβ subunit could affect the binding of a second
protein to a different part of the same Gβ molecule.
Rhes has complex effects on GPCR signalling [18,
19]. It attenuates signalling by GPCRs that function
through Gαs but does not appear to affect signalling
through Gαi subunits. The effect on Gαs signalling
appears to be at the level of activation of the heterotrimer
Gαβγ complex as constitutively active receptors are
affected, but constitutively active Gαs subunits are not,
and Rhes has no effect on direct activation of the cAMP/
PKA pathway by forskolin. These results suggest that
Rhes can affect the coupling of GPCRs to Gαs subunits.
The interaction of Rhes with Gβ subunits revealed in our
study could provide a mechanism for this inhibition, either
by disrupting the formation of heterotrimeric G proteins
or inhibiting the interaction of the heterotrimer with the
receptor. Rhes appears perfectly located within the cell
to have such affects. Like the G protein subunits, Rhes is
not an integral membrane protein but associates with the
plasma membrane through post-translational
modifications. For Rhes, this is via prenylation of a
conserved CAAX motif at its C-terminus [18]. Gγ subunits
are also C-terminally prenylated, Gαs subunits are N-
terminally palmitoylated, and Gαi subunits are both
palmitoylated and myristoylated at the N-terminus
(reviewed by [31]). Gβ subunits associate indirectly with
membranes though interaction with the Gγ subunits, and
this could be sensitive to inhibition by the membrane
localised Rhes.
Why Rhes affects only Gαs signalling, and not Gαi
signalling, is an interesting challenge [18]. One possibility
could relate to the Gβ-specificity of Rhes (Figure 2A)
and it might be, for example, that Gαs subunits interact
preferentially with Gβ1-3 (and thus be affected by Rhes)
whereas Gαi subunits are more often complexed with
Gβ4-5 (and not affected by Rhes). Alternatively, Gαi may
be less susceptible than Gαs to disruption by Rhes
because Gαi has a stronger interaction with the plasma
membrane and may be better able to interact with Gβγ
subunits and/or receptors. Gαi is both myristoylated and
palmitoylated whereas Gαs is only palmitoylated and
requires interaction with Gβγ subunits for full membrane
association, the prenylated Gγ subunit providing a second
membrane anchor [32] (reviewed by [33]). Indeed, Gαs
associates poorly with membranes in the absence of Gβγ
subunits, and requires this interaction for efficient
palmitoylation [34]. The greater membrane association
of Gαi may overcome the inhibitory effects of Rhes more
readily than Gαs.
As a final consideration, Rhes functions
independently of G proteins, binding to effector proteins
such as Raf and phosphoinositide 3-kinase [18]. It will be
interesting to determine if these more traditional targets
for Ras-like proteins also interact with the cationic region
of Rhes or whether they interact with other parts of the
Rhes molecule.
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